StratifAI, the AI precision oncology company behind the Polaris™ platform, today announced its selection for the ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology ...
BV usually recurs (meaning, it comes back). Up to 66% percent of women with bacterial vaginosis will have it again within a ...
Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the randomized, double-blind, phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback